Infection control market seen hitting $213.38B by 2035

Market Research Future projects the global infection control market will grow from $117.06 billion in 2026 to $213.38 billion by 2035, powered by regulation, sterilization upgrades and AI-based surveillance. North America leads now, while Asia-Pacific is expected to post the fastest growth through hospital expansion and public-health modernization.

Why it matters: - Infection control is moving from a clinical back-office function to a budget priority tied to reimbursement, regulation and hospital expansion. - The market’s growth reflects rising demand for sterilization, disinfection, monitoring and outsourced compliance services across hospitals, clinics, labs and manufacturers. - The projected expansion from $117.06 billion in 2026 to $213.38 billion by 2035 implies steady long-term spending on infection-prevention infrastructure.

What happened: - Market Research Future projected the global infection control market at $213.38 billion by 2035, up from $117.06 billion in 2026. - The forecast implies a 6.90% CAGR over 2026-2035. - The market base was estimated at $109.50 billion in 2025. - The report identified CMS reimbursement penalties, EPA ethylene oxide rules and Asia-Pacific hospital construction as major growth drivers. - A free sample and custom report requests are available through the company’s sample request page and customization page.

The details: - CMS Hospital-Acquired Condition Reduction Program penalties can withhold up to 3% of hospital reimbursements from facilities with elevated hospital-acquired infection rates. - Roughly 750 U.S. hospitals are penalized annually under the CMS program. - The penalty structure has redirected an estimated $1.8 billion into upgraded environmental cleaning systems, automated hand-hygiene monitoring and real-time surveillance over the past three years. - EPA finalized updated emission limits in Q4 2024 that require commercial sterilization facilities to cut ethylene oxide emissions by up to 90%. - Hospitals are shifting from centralized ethylene oxide workflows to low-temperature hydrogen peroxide gas plasma and vaporized peracetic acid systems. - That replacement cycle is valued at more than $2.5 billion across North America and Western Europe through 2030. - A single hydrogen peroxide gas plasma sterilizer costs about $120,000 to $180,000, before consumable cassettes. - Consumable cassettes add about $15 to $25 per cycle. - The installed base of low-temperature sterilizers in U.S. hospitals grew an estimated 22% from 2022 to 2025. - AI-driven infection surveillance platforms combine electronic health records, hand-hygiene sensor data and environmental microbiology results. - Those platforms can detect outbreak clusters 48 to 72 hours earlier than manual chart review. - Health systems using the platforms report 15% to 22% reductions in hospital-acquired infection rates within the first 18 months. - Ecolab acquired a cloud-based hand-hygiene compliance monitoring platform in 2023. - Autonomously operated UV-C disinfection robots are expected in more than 15,000 acute-care facilities worldwide by 2030, up from about 4,500 in 2025. - Contract infection control services are forecast to grow at a 7.10% CAGR through 2035. - Those operators spread compliance infrastructure across 20 to 40 client facilities and achieve 30% to 40% lower per-cycle costs than single-site departments. - Asia-Pacific is projected to grow at a 7.35% CAGR through 2035. - China’s Healthy China 2030 plan targets 8.0 hospital beds per 1,000 people by 2030, up from 6.7 in 2023. - Provincial governments in China have committed more than $45 billion to hospital construction and renovation from 2023 to 2028. - India’s Ayushman Bharat scheme has funded more than 150,000 Health and Wellness Centers.

Between the lines: - The market is being shaped less by elective procurement and more by forced replacement cycles and compliance mandates. - Infection control spending is shifting toward integrated product-service bundles, data-enabled monitoring and lower-emission sterilization technologies. - Outsourcing is gaining appeal because it turns high fixed compliance costs into recurring service fees. - The competitive edge is moving toward vendors that combine hardware, consumables, analytics and service coverage.

What's next: - Low-temperature sterilization demand is likely to stay elevated as hospitals replace ethylene oxide-dependent systems. - AI-powered surveillance and automated disinfection should keep gaining traction as hospitals look for earlier outbreak detection and labor savings. - Asia-Pacific hospital buildouts and outpatient growth are expected to keep the region the fastest-growing contributor through 2035. - Contract sterilization and managed infection-control models are likely to expand as smaller facilities seek lower capital burdens.

The bottom line: - Infection control is entering a regulatory-driven upgrade cycle, with equipment replacement, AI monitoring and outsourced services expected to power growth through 2035.